Researchers at the University of Michigan (U-M) devised a process to grow a series of honeycomb-like arrays of tiny, lab-grown cancers that could one day help doctors zero in on individualized treatments for ovarian cancer. The findings are detailed in a study in the journal, Clinical Cancer Research. Led by…...
Prostate cancer is never thwarted by the politics of avoidance. Over half of men aged 50 and over have already experienced changes to the tissues and cells in their prostate, which is part of the normal aging process. The likelihood of developing prostate cancer increases with age. While only one…...
When a diagnosis of cancer is delivered to a patient, the effect is obviously traumatic. This trauma is not self-limiting. The people who love and care for those with cancer have their lives irrevocably impacted, as well. Individuals find themselves in a role they hadn’t anticipated playing: that of caregiver…...
Researchers have ascertained that the anti-tapeworm drug, nitazoxanide (NTZ), may also hold out hope as a precision therapy for various cancers. Prostate and colon cancer cells contain high amounts of activated beta-catenin, which correlate to treatment-resistant cancer cells and other oncological parameters. In a study of the cancer-abetting potential of…...
BALTIMORE — A study led by a Johns Hopkins Bloomberg School of Public Health researcher indicates nearly one-third of breast cancer surgery patients went against their doctor’s advice, choosing to not begin or complete adjuvant anti-cancer therapy. The primary factor: a general mistrust of the American healthcare system. Adjuvant therapy…...
Free Cancer Screening Guidelines
National Foundation for Cancer Research(NFCR) is a 501(c)(3) tax-exempt nonprofit organization.
Tax ID #: 04-2531031
5515 Security Lane, Suite 1105 Rockville, MD 20852
